admitted to the hospital. The patients included children, adults and elderly people.
Introduction
Shigellosis still remains a public health problem in most developing countries because of the poverty, poor sanitation, personal hygiene and poor water supply. [1] Literature review shows that about 140 million people suffer from shigellosis with estimated 600,000 deaths per year world-wide. [2, 3] It is a major cause of dysentery/diarrhea in children and others. Many of them are hospitalized immediately after the onset of the disease. Though, oral rehydration is the principal means of management, because of the enteroinvasiveness antibacterial treatment may be necessary. [1] The number of multiresistant strains are increasing regularly not only in different parts of the country, but also world-wide. [1] [2] [3] [4] [5] [6] [7] [8] Hence the study was carried out to determine the antibiotic susceptibility proÞ le of Shigella spp. in Bangalore.
Materials and Methods
During January 2002 to December 2007, 2941 stool samples were collected from diarrhoeal/dysenteric patients 29 (21.6%). S. boydii was isolated in 11 (8.2%) and S. dysenteriae in 5 (3.7%) of the total number of isolates (Table 1 Figure. 
Discussion
Shigellosis is endemic in our region as evidenced by the continued isolation of Shigella over the 5 year period. In this study, we isolated 134(5.4%) Shigella strains from diarrhoeal/dysenteric stools of 2491 patients. The percentage over 5 years varied between 2.8% to 5.9%. This was similar to the Vellore data, 3.9% in 2001. [4] The pattern of Shigellosis indicates that S. ß exneri was the predominant and most active serogroup in Bangalore during the years. The numbers of faecal samples submitted to the laboratory were more or less similar in all the 5 years, but in 2004 more Shigella were isolated (5.9%). This increase in isolation of Shigella seems to be real and not due to increased number of stool cultures during that period. A minor outbreak could be the reason behind the increase.
The pattern of Shigellosis indicates that S. ß exneri was the predominant and most active serogroup in Bangalore during the years. However, in 2003 and 2004, S. boydii was isolated from 18% of cases reducing S. ß exneri from near 70% to 50%. In 2007, S. sonnei had been reduced by 10% and the isolation rate of S. ß exneri increased from 70% to 80% (Table 1 ). This cyclic change agrees with the pattern observed in Puducherry and Kolkata where cyclical serogroup change had been observed over the years. [6, 8] Analysis by age showed that 56 (41.8%) were from pediatric age group (0-14 years). The clinical course was found to be more severe in children superadded with malnutrition. This calls for an urgent measure to reduce the deaths in children due to Shigellosis. Therefore, public health strategy should ensure clean water supply, good sewage management and a clean environment.
Analysis of the antibiotic susceptibility data showed a gradual increase in resistance to Ampicillin, ß uctuating resistance to Chloramphenicol and persistent resistance to Co-trimoxazole. Over 70% of Shigella isolates were resistant to two or more drugs including Ampicillin and Co-trimoxazole. Similar Þ ndings were reported from Manipal, South India by Mamata et al. [7] and overall 90% were reported from Kolkata by Niyogi et al. [5] In our study, there is a gradual increase in Ampicillin resistance, 46. . Similar high rate of resistance was reported in Vellore and Kolkata. [4, 5] Flouroquinolone resistance was noted in 2004 (5.9%) and gradually increased to 48.5% in 2007. A similar trend of increased Ciproß oxacin resistance has been observed in other parts of India. [6, 8] The molecular characterization of 60 strains has been done by Gururaj et al. between 2001 and 2004 . [11] Their Þ ndings showed that Flouroquinolone resistant strains had a uniform mutation in Gyr-A at position 83 (replacement of serine with leucine and the majority of strains had a second mutation at position 87 with replacement of aspartic acid with either glycine or aspargine. The clinical course though was more severe in Ciproß oxacin resistant cases, no mortality was observed in our study. These patients were treated symptomatically as well as with a third generation Cephalosporin. The emergence of Flouroquinolone resistant Shigella has a bearing on therapy of Shigellosis as many clinicians empirically prescribe Flouroquinolones for many infections like diarrhea and urinary tract infection. Thus with the emergence of high resistance there is a need for alternate drugs. Most of the isolates were susceptible to Neomycin and Furazolidine. All were susceptible to Ceftriaxone. This was similar to the study by Mamatha et al. at Manipal. [7] Recently however in January 2009 we have isolated a strain of S. ß exneri resistant to Ceftriaxone with MIC 64µg/ml (conÞ rmed by Vitek 2C), simultaneously resistant to Ampicillin, Co-trimoxazole, Chloramphenicol, Nalidixic acid, Ciproß oxacin and Furazolidine. Though the patient was managed symptomatically, spread of the clone may pose a greater threat to the community. More data are required from different parts of the country to support our Þ nding. Data from the literature suggest that Azithromycin and Mecillinam have shown promise in treatment of Shigellosis. [12, 13] The study shows the occurrence of drug resistant Shigellosis. Antibiotics may not be necessary for mild cases and if required should be guided by local data. The continuous surveillance of multidrug resistant strains is very important to know the changing antibiotic susceptibility pattern as well as the cyclical change of the serogroup from time to time as the resistance pattern also changes with the change in the serogroup. Analysis and periodic reporting is important in proper therapy of Shigellosis.
